Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

China says US COVID origins report lacks credibility

November 1, 2021 Sales and Marketing

A US intelligence report saying it was plausible that COVID-19 originated in a Wuhan laboratory has been deemed unscientific and …
News

FDA issue Pfizer vaccine emergency clearance for children, and delay Moderna

November 1, 2021 Sales and Marketing

The FDA has informed Moderna that it needs more time to review the company’s COVID vaccine in children aged 12 …
News

Study reveals high efficacy of Sputnik V in protecting aged 60+ against COVID

November 1, 2021 Sales and Marketing

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) has announced the results of a real world study by …
News

Infectious disease expert says children between 5-11 could be vaccinated in November

October 25, 2021 Sales and Marketing

Infectious disease expert, Dr Anthony Fauci, has said that COVID-19 vaccines for children aged 5-11 could be available by early …
News

More people self-funding routine operations as NHS waiting lists hit record levels

October 25, 2021 Sales and Marketing

New data from the Private Healthcare Information Network (PHIN) reveals that people are increasingly opting to self-fund private treatment. This …
News

Novartis Phase III study into canakinumab does not meet primary endpoint

October 25, 2021 Sales and Marketing

Novartis have announced that their CANOPY-1 Phase III study, which evaluated the efficacy of canakinumab, did not meet its primary …
News

AstraZeneca biliary cancer drug shows improved survival rate in patients

October 25, 2021 Sales and Marketing

AstraZeneca has announced that its Imfinzi drug­­­, for the treatment of biliary tract cancer, has improved overall survival in patients …
News

Survey reveals efficacy of Pfizer and AstraZeneca vaccines against positive COVID-19 tests

October 18, 2021 Sales and Marketing

Data from the Coronavirus Infection Survey (CIS), and pillars 1 and 2 of the NHS Test and Trace have measured …
News

MindMaze and The Royal Buckinghamshire Hospital create brain repair platform

October 18, 2021 Sales and Marketing

MindMaze Healthcare, major leader in the multi billion-dollar digital neurotherapeutics market, has announced the first UK partnership for its MindPod™ …
News

Major trial proposes how to reduce ICU infections caused by staphylococcus aureus

October 18, 2021 Sales and Marketing

A major US hospital-based clinical trial has highlighted the benefit of using nasal decolonisation to reduce ICU infections caused by …
News

Valneva COVID-19 vaccine shown to be more effective than AstraZeneca candidate

October 18, 2021 Sales and Marketing

French biotech company, Valneva, has announced positive results from the Phase III trial of its inactivated, adjuvanted COVID-19 vaccine candidate, …
News
limbix

SparkRx depression therapeutic shown to cut depression symptoms in adolescents

October 11, 2021 Sales and Marketing FDA, Limbix, SparkRx

A new digital therapeutic available for use without prescription under the FDA’s emergency guidance for digital health devices has shown …
News

NICE approves treatment for rheumatoid arthritis

October 11, 2021 Sales and Marketing

NICE has issued a positive final appraisal document recommending upadacitinib, a once-daily oral therapy, for people with previously treated moderate …
News
1109181692_a148e995c4_c

AlzeCure’s Alzheimer project initiates Phase I study

October 4, 2021 Sales and Marketing

Swedish pharmaceutical company AlzeCure Pharma AB has announced the initiation of the company’s next clinical Phase I trial (multiple ascending …
News

SEED invests in CBD brand business

October 4, 2021 Sales and Marketing

SEED Innovations Ltd has announced that it has invested a further £150,000 in South West Brands Limited (SWB), a multi-brand …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026